Literature DB >> 18485320

Re: efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Brian Shuch1, Arie Belldegrun.   

Abstract

Entities:  

Year:  2008        PMID： 18485320     DOI： 10.1016/j.eururo.2008.02.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome sequencing study.

Authors:  Yuan Ren; Kunpeng Liu; Xueling Kang; Lijuan Pang; Yan Qi; Zhenyan Hu; Wei Jia; Haijun Zhang; Li Li; Jianming Hu; Weihua Liang; Jin Zhao; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Targeting the mTOR pathway in Chromophobe Kidney Cancer.

Authors:  Brian Shuch; Srinivas Vourganti; Julia C Friend; Lee M Zehngebot; W Marston Linehan; Ramaprasad Srinivasan
Journal:  J Cancer       Date:  2012-04-02       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.